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Abstract 
Introduction & Hypothesis: Diabetes is one of the major risk factor for cardiovascular 
diseases. Prolonged exposure to uncontrolled hyperglycaemia in the heart induces 
dramatic metabolic changes that alter tissue homeostasis providing basis for the so called 
“metabolic memory”. Although epigenetic mechanisms have been described contributing 
to this process, the molecular events that establish metabolic memory remain elusive. 
Recent reports revealed that stable oxidation derivatives of methylated cytosines (5mC) 
such as 5-hydroxymethyl (5hmC) and 5-formyl (5fC) cytosines may accumulate in the 
heart upon age but none of these changes has been associated yet to metabolic memory 
or diabetes. Prior work described that human cardiac stromal cells isolated from diabetic 
donors (D-CSMCs) displayed stable epigenetic alterations including enrichment of 5mC. 
We queried here about the existence of an epi-metabolic control circuit capable of 
regulating DNA demethylation enzymatic machinery and the onset of metabolic memory 
diabetic tissues and cells. 
Methods & Results: An integrated genomic, transcriptomic and metabolomic approach 
revealed that 5mC, 5hmC and 5fC accumulated in genomic and mitochondrial DNA from 
hearts of diabetic mice and in D-CMSCs. Specifically, RNA-seq indicated repression of 
genes associated to proliferation, transcription, DNA repair and metabolism while 
metabolomics provided evidence of a reduction in alpha-ketoglutaric acid (αKG) synthesis. 
Notably, αKG deficiency compromised ten eleven translocation (TET) and thymine DNA 
glycosylase (TDG) complex formation and function. Providing an exogenous source of 
αKG to cells, in fact, reactivated TET and TDG and reduced the genomic content of 
modified cytosines. To select more specific modulators a drug screening was performed to 
select small molecule regulators of αKG synthesis and DNA demethylation. The newly 
identified compound, AA6, increased the intracellular content of αKG and activated TET 
and TDG resulting in genomic demethylation and functional rescue of type 2 diabetic mice 
and human cells. 
Conclusions: The epi-metabolic modulation of DNA demethylation promises novel future 
therapeutic strategies aimed at prevention/treatment of diabetic cardiac complications. 
 
